Medrol

Methylprednisolone, the active ingredient in Medrol, is a corticosteroid presented as an oral tablet for oral use. It provides anti‑inflammatory and immunosuppressive effects and is prescribed for a range of allergic, respiratory and autoimmune conditions in both adults and children as directed by a healthcare professional.

GNH USA supplies Medrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medrol is a corticosteroid that modulates inflammatory and immune pathways across several disease families.

- Allergic disorders: reduces inflammation and alleviates symptoms such as swelling, itching and hives. - Asthma: diminishes airway inflammation, improving breathing and reducing exacerbations. - Rheumatoid arthritis: decreases joint inflammation and pain, helping preserve mobility. - Dermatologic diseases: controls severe skin inflammation in conditions like eczema and psoriasis. - Autoimmune conditions: suppresses immune over‑activity in diseases such as systemic lupus erythematosus.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Increased appetite or weight gain. - Elevated blood glucose levels. - Mood changes, including anxiety or insomnia. - Gastrointestinal discomfort such as nausea or indigestion. - Fluid retention causing mild swelling.

Serious or Rare Side Effects: - Severe infections due to immunosuppression. - Osteoporosis or bone fractures with long‑term use. - Adrenal insufficiency upon abrupt discontinuation. - Vision problems such as cataracts or glaucoma. - Uncontrolled hypertension or cardiovascular events.

Before initiating therapy, consider the following safety measures.

- Assess infection risk: avoid use in active, uncontrolled infections. - Monitor blood glucose: patients with diabetes may need dose adjustments. - Evaluate bone health: consider calcium and vitamin D supplementation for long‑term therapy. - Screen for psychiatric history: corticosteroids can exacerbate mood disorders. - Review gastrointestinal history: use with caution in patients with peptic ulcer disease. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Methylprednisolone may alter the activity of several concomitant medicines.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, phenytoin) that may reduce steroid efficacy. - Live vaccines: increased risk of disseminated infection.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of gastrointestinal bleeding. - Anticoagulants (warfarin): possible enhancement of anticoagulant effect. - Diabetic agents: may require dose adjustments due to altered glucose control. - Antihypertensives: corticosteroids can blunt blood‑pressure‑lowering effects.